Rare diseases
Investigational molecules
Locations
Back to Spain56 clinical trials in Logrono, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease
SpainStudy on the Safety and Effects of VERT-002 for Patients with Advanced Solid Tumors, Including Lung Cancer with MET Alterations
SpainStudy of Temocillin and Meropenem for Patients with Infections Caused by Resistant Enterobacteriaceae
SpainStudy of ASP1570 Alone or with Pembrolizumab for Adults with Advanced Solid Tumors
SpainStudy on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis
SpainStudy on the Effectiveness and Safety of 7 vs. 14 Days of Antibiotic Treatment with Meropenem for Patients with Pseudomonas Aeruginosa Blood Infection
SpainStudy Comparing Lenalidomide, Bortezomib, Dexamethasone, Isatuximab, and Iberdomide for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant
SpainStudy on Evolocumab for Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on non-muscle invasive bladder cancer treatment, comparing electric current-administered mitomycin C with standard immunotherapy. Research includes evaluation of novel biomarkers for tumor detection.
Advanced therapeutic approaches combining traditional and innovative treatment methods.
Clinical research examining treatment outcomes for severe acute alcoholic hepatitis, investigating the effectiveness of combination therapy using methylprednisolone and N-acetylcysteine.
Focus on improving survival rates in severe cases.
Comprehensive studies on bacterial infections, including Pseudomonas aeruginosa bacteremia and Enterobacteriales infections. Evaluation of optimal antibiotic treatment durations and alternative therapeutic approaches.
Advancing antimicrobial stewardship through evidence-based research.
Breakthrough studies in multiple sclerosis treatment, comparing the efficacy of remibrutinib versus teriflunomide in managing relapsing forms of the disease.
Focused on improving quality of life for MS patients.
Investigation of treatment strategies for acute myocardial infarction, evaluating evolocumab's effectiveness in reducing cardiovascular events and hospitalizations.
Emphasis on real-world clinical outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
